These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30036313)

  • 1. Methamphetamine and the risk of pulmonary arterial hypertension.
    Ramirez RL; Perez VJ; Zamanian RT
    Curr Opin Pulm Med; 2018 Sep; 24(5):416-424. PubMed ID: 30036313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.
    Zamanian RT; Hedlin H; Greuenwald P; Wilson DM; Segal JI; Jorden M; Kudelko K; Liu J; Hsi A; Rupp A; Sweatt AJ; Tuder R; Berry GJ; Rabinovitch M; Doyle RL; de Jesus Perez V; Kawut SM
    Am J Respir Crit Care Med; 2018 Mar; 197(6):788-800. PubMed ID: 28934596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
    Kolaitis NA; Zamanian RT; de Jesus Perez VA; Badesch DB; Benza RL; Burger CD; Chakinala MM; Elwing JM; Feldman J; Lammi MR; Mathai SC; McConnell JW; Presberg KW; Robinson JC; Sager J; Shlobin OA; Simon MA; Kawut SM; Glidden DV; Singer JP; De Marco T;
    Ann Am Thorac Soc; 2021 Apr; 18(4):613-622. PubMed ID: 33064950
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening Of Pulmonary Hypertension in Methamphetamine Abusers (SOPHMA): rationale and design of a multicentre, cross-sectional study.
    Cheng Y; Tung CK; Chung AKK; Liu WW; Huang D; Chan PH; Lam M; Chan WC; Siu CW; Hai JJ
    BMJ Open; 2019 Aug; 9(8):e027193. PubMed ID: 31375608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine-associated pulmonary arterial hypertension.
    Kolaitis NA; Saggar R; De Marco T
    Curr Opin Pulm Med; 2022 Sep; 28(5):352-360. PubMed ID: 35838374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary Arterial Hypertension and Dilated Cardiomyopathy.
    Zhao SX; Kwong C; Swaminathan A; Gohil A; Crawford MH
    JACC Heart Fail; 2018 Mar; 6(3):209-218. PubMed ID: 29496022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension.
    Charoenpong P; Hall NM; Keller CM; Ram AK; Murnane KS; Goeders NE; Dhillon NK; Walter RE
    Chest; 2024 Jun; 165(6):1518-1533. PubMed ID: 38211700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH.
    Clements PJ; Tan M; McLaughlin VV; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ; Langer A;
    Ann Rheum Dis; 2012 Feb; 71(2):249-52. PubMed ID: 21998119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulants and Pulmonary Arterial Hypertension: An Update.
    Ramirez RL; De Jesus Perez V; Zamanian RT
    Adv Pulm Hypertens; 2018; 17(2):49-54. PubMed ID: 31656550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?
    Chin KM; Channick RN; Rubin LJ
    Chest; 2006 Dec; 130(6):1657-63. PubMed ID: 17166979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: diagnostic approach of a single center].
    Kayikçioğlu M; Kültürsay H
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):279-85. PubMed ID: 18676304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. United States Pulmonary Hypertension Scientific Registry: Baseline Characteristics.
    Badlam JB; Badesch DB; Austin ED; Benza RL; Chung WK; Farber HW; Feldkircher K; Frost AE; Poms AD; Lutz KA; Pauciulo MW; Yu C; Nichols WC; Elliott CG;
    Chest; 2021 Jan; 159(1):311-327. PubMed ID: 32858008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases.
    Girgis RE; Mathai SC; Krishnan JA; Wigley FM; Hassoun PM
    J Heart Lung Transplant; 2005 Oct; 24(10):1626-31. PubMed ID: 16210140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary hypertension and right ventricular failure. Part VII. Epidemiology, risk factors, and pathogenesis of primary (idiopathic) pulmonary arterial hypertension].
    Batyraliev TA; Makhmutkhodzhaev SA; Esinci E; Pataraia SA; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV
    Kardiologiia; 2007; 47(2):44-56. PubMed ID: 17495821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.
    Tedford RJ; Mudd JO; Girgis RE; Mathai SC; Zaiman AL; Housten-Harris T; Boyce D; Kelemen BW; Bacher AC; Shah AA; Hummers LK; Wigley FM; Russell SD; Saggar R; Saggar R; Maughan WL; Hassoun PM; Kass DA
    Circ Heart Fail; 2013 Sep; 6(5):953-63. PubMed ID: 23797369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pulmonary arterial hypertension in connective tissue disease.
    Grünig E
    Drugs; 2012 May; 72(8):1039-56. PubMed ID: 22621693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of therapeutic agents for the management of pulmonary arterial hypertension.
    Hahn SS; Makaryus M; Talwar A; Narasimhan M; Zaidi G
    Ther Adv Respir Dis; 2017 Jan; 11(1):46-63. PubMed ID: 27595643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
    Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.